Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases Dividend to $15.10 Per Share

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced a dividend on Thursday, May 16th, investing.com reports. Shareholders of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date is Monday, May 20th. This is a positive change from Merrimack Pharmaceuticals’s previous dividend of $1.50.

Merrimack Pharmaceuticals Stock Performance

Shares of Merrimack Pharmaceuticals stock opened at $15.13 on Friday. The firm has a market capitalization of $223.77 million, a PE ratio of 1.09 and a beta of 1.45. Merrimack Pharmaceuticals has a 12 month low of $11.53 and a 12 month high of $15.89. The business’s 50-day moving average price is $14.81 and its 200-day moving average price is $13.87.

Merrimack Pharmaceuticals (NASDAQ:MACK) last issued its quarterly earnings results on Wednesday, May 15th. The biopharmaceutical company reported ($0.03) EPS for the quarter.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of Merrimack Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday, May 13th.

Merrimack Pharmaceuticals Company Profile

Merrimack Pharmaceuticals, Inc operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.